Anti-TSG101 antibody produced in rabbit, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution

Synonyms: Anti-Tumor Suspectibility Gene 101

MDL No.: MFCD08705528

Storage: -20C

UNSPSC Code: 12352203

General description: Tumor susceptibility 101 (TSG101) is encoded by the gene mapped to human chromosome 11p15.1-15.2. The encoded protein is a member of catalytically inactive ubiquitin E2 variant (UEV) family. Tsg101 is characterized with an ubiquitin E2 variant (UEV) domain in its N-terminal end involved in HIV-1 budding and the vacuolar protein sorting (VPS) pathway.

Application: Anti-TSG101 antibody produced in rabbit has been used for western blotting.

Biochem/physiol Actions: Tumor susceptibility 101 (TSG101) is implicated in various cellular function such as, ubiquitination, transcriptional regulation, endosomal trafficking and cell proliferation. Mutation in the gene leads to various human cancers.Tsg101 plays a crucial role in cell growth, cell survival, and normal function of embryonic and adult tissues. TSG101 facilitates infectious human immunodeficiency virus (HIV-1) budding by linking the p6 late domain to vacuolar protein sorting machinery. Tsg101 is a vital constituent of the endosomal sorting complex required for transport (ESCRT) machinery, that helps in synthesis of multi-vesicular bodies, mainly the formation and scission of the intraluminal vesicles, and is thus, crucial for the degradation and recycling of receptors localized on plasma membrane. Tsg101 expression is controlled by an intrinsic autoregulatory mechanism and by ubiquitination catalyzed by various ubiquitin ligases.

Immunogen: syntheitic peptide corresponding to amino acids 254-272 located near the C-terminus of human TSG101, conjugated to KLH. This sequence is identical in rat and mouse TSG101.

Physical form: Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium axide.